These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37685704)

  • 41. Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy.
    Banihani R; Smile S; Yoon G; Dupuis A; Mosleh M; Snider A; McAdam L
    J Child Neurol; 2015 Oct; 30(11):1472-82. PubMed ID: 25660133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced levels of dystrophin associated proteins in the brains of mice deficient for Dp71.
    Greenberg DS; Schatz Y; Levy Z; Pizzo P; Yaffe D; Nudel U
    Hum Mol Genet; 1996 Sep; 5(9):1299-303. PubMed ID: 8872469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression.
    Daoud F; Angeard N; Demerre B; Martie I; Benyaou R; Leturcq F; Cossée M; Deburgrave N; Saillour Y; Tuffery S; Urtizberea A; Toutain A; Echenne B; Frischman M; Mayer M; Desguerre I; Estournet B; Réveillère C; Penisson-Besnier ; Cuisset JM; Kaplan JC; Héron D; Rivier F; Chelly J
    Hum Mol Genet; 2009 Oct; 18(20):3779-94. PubMed ID: 19602481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
    Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
    JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical utilisation of multimodal quantitative magnetic resonance imaging in investigating muscular damage in Duchenne muscular dystrophy: a study on the association between gluteal muscle groups and motor function.
    Song Y; Xu HY; Xu K; Guo YK; Xie LJ; Peng F; Xu R; Fu H; Yuan WF; Zhou ZQ; Cheng BC; Fu C; Zhou H; Cai XT; Li XS
    Pediatr Radiol; 2023 Jul; 53(8):1648-1658. PubMed ID: 36892624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synaptic alterations as a neurodevelopmental trait of Duchenne muscular dystrophy.
    De Stefano ME; Ferretti V; Mozzetta C
    Neurobiol Dis; 2022 Jun; 168():105718. PubMed ID: 35390481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lentiviral Micro-dystrophin Gene Treatment into Late-stage mdx Mice for Duchenne Muscular Dystrophy Disease.
    Eren SA; Tastan C; Karadeniz KB; Turan RD; Cakirsoy D; Kancagi DD; Yilmaz SU; Oztatlici M; Oztatlici H; Ozer S; Tumentemur G; Baykal AT; Ovali E
    Curr Gene Ther; 2023; 23(4):304-315. PubMed ID: 37032509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical study on cognitive impairment in Duchenne muscular dystrophy.
    Zhang XF; Luo YY; Jiang L; Hong SQ
    Neuromuscul Disord; 2023 Jul; 33(7):596-604. PubMed ID: 37385106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up.
    Desguerre I; Christov C; Mayer M; Zeller R; Becane HM; Bastuji-Garin S; Leturcq F; Chiron C; Chelly J; Gherardi RK
    PLoS One; 2009; 4(2):e4347. PubMed ID: 19194511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site.
    D'Angelo MG; Lorusso ML; Civati F; Comi GP; Magri F; Del Bo R; Guglieri M; Molteni M; Turconi AC; Bresolin N
    Pediatr Neurol; 2011 Nov; 45(5):292-9. PubMed ID: 22000308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy.
    Iftikhar M; Frey J; Shohan MJ; Malek S; Mousa SA
    Pharmacol Ther; 2021 Apr; 220():107719. PubMed ID: 33130193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nuclear Small Dystrophin Isoforms during Muscle Differentiation.
    Donandt T; Todorow V; Hintze S; Graupner A; Schoser B; Walter MC; Meinke P
    Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual task impact on functional mobility and interaction of functional level and balance in patients with Duchenne muscular dystrophy.
    Savas-Kalender D; Kurt-Aydin M; Acarol FO; Tarsuslu T; Yis U
    Gait Posture; 2024 Feb; 108():282-288. PubMed ID: 38171184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation.
    Pane M; Lombardo ME; Alfieri P; D'Amico A; Bianco F; Vasco G; Piccini G; Mallardi M; Romeo DM; Ricotti V; Ferlini A; Gualandi F; Vicari S; Bertini E; Berardinelli A; Mercuri E
    J Pediatr; 2012 Oct; 161(4):705-9.e1. PubMed ID: 22560791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy.
    Wong TWY; Cohn RD
    Curr Gene Ther; 2017; 17(4):301-308. PubMed ID: 29173172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of short dystrophin isoform Dp71 in olfactory ensheathing cells causes vomeronasal nerve defasciculation in mouse olfactory system.
    Takatoh J; Kudoh H; Kondo S; Hanaoka K
    Exp Neurol; 2008 Sep; 213(1):36-47. PubMed ID: 18586242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients.
    Zhang Y; Yang W; Wen G; Wu Y; Jing Z; Li D; Tang M; Liu G; Wei X; Zhong Y; Li Y; Deng Y
    Mol Genet Genomic Med; 2019 May; 7(5):e622. PubMed ID: 30938079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.